BIO-Key Stock Today

BKYI
 Stock
  

USD 0.96  0.04  4.00%   

Market Performance
0 of 100
Odds Of Distress
Less than 41
BIO-Key International is trading at 0.96 as of the 5th of December 2022. This is a -4 percent decrease since the beginning of the trading day. The stock's open price was 1.0. BIO-Key International has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for BIO-Key International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of November 2022 and ending today, the 5th of December 2022. Click here to learn more.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company has 8.47 M outstanding shares of which 76.54 K shares are currently shorted by private and institutional investors with about 4.9 trading days to cover. More on BIO-Key International

Moving against BIO-Key International

-0.87LSCCLattice Semiconductor Tech BoostPairCorr
-0.84CROXCrocs Inc Downward RallyPairCorr
-0.82GOCOGohealthLlc Upward RallyPairCorr
-0.78MCHPMicrochip Technology Tech BoostPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

BIO-Key International Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BIO-Key International's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BIO-Key International or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
BIO-Key International generated a negative expected return over the last 90 days
BIO-Key International has some characteristics of a very speculative penny stock
BIO-Key International has high historical volatility and very poor performance
The company reported the previous year's revenue of 5.11 M. Net Loss for the year was (5.07 M) with profit before overhead, payroll, taxes, and interest of 3.44 M.
BIO-Key International currently holds about 4.89 M in cash with (8.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
MD ViceChairmanKwok Wong
Fama & French Classification
Average Analyst Recommendation
Analysts covering BIO-Key International report their recommendations after researching BIO-Key International's financial statements, talking to executives and customers, or listening in on BIO-Key International's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering BIO-Key International. The BIO-Key consensus assessment is calculated by taking the average forecast from all of the analysts covering BIO-Key International.
Strong Buy1 Opinion
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BIO-Key International's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
BIO-Key International (BKYI) is traded on NASDAQ Exchange in USA and employs 51 people. BIO-Key International is listed under Systems Software category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with current market capitalization of 8.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BIO-Key International's market, we take the total number of its shares issued and multiply it by BIO-Key International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BIO-Key International conducts business under Software sector and is part of Information Technology industry. The entity has 8.47 M outstanding shares of which 76.54 K shares are currently shorted by private and institutional investors with about 4.9 trading days to cover. BIO-Key International currently holds about 4.89 M in cash with (8.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check BIO-Key International Probability Of Bankruptcy
Ownership
BIO-Key International shows 9.967 percent if its outstanding shares held by insiders and 9.967 percent owned by other corporate entities .

Ownership Allocation (%)

Check BIO-Key Ownership Details

BIO-Key Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of BIO-Key International jumping above the current price in 90 days from now is about 99.0%. The BIO-Key International probability density function shows the probability of BIO-Key International stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days BIO-Key International has a beta of 0.2442 suggesting as returns on the market go up, BIO-Key International average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BIO-Key International will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. BIO-Key International is significantly underperforming NYSE Composite.
  Odds Below 0.96HorizonTargetOdds Above 0.96
1.32%90 days
 0.96 
98.67%
Based on a normal probability distribution, the odds of BIO-Key International to move above the current price in 90 days from now is about 99.0 (This BIO-Key International probability density function shows the probability of BIO-Key Stock to fall within a particular range of prices over 90 days) .

BIO-Key Stock Institutional Holders

Institutional Holdings refers to the ownership stake in BIO-Key International that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BIO-Key International's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BIO-Key International's value.
InstituionSecurity TypeTotal SharesValue
Wolverine Trading LlcCommon Shares15.6 K38 K
Wolverine Trading LlcPut Options27.9 K68 K
Wolverine Trading LlcCall Options19.2 K46 K
Wolverine Trading LlcCommon Shares11.8 K26 K
View BIO-Key International Diagnostics

BIO-Key International Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. BIO-Key International market risk premium is the additional return an investor will receive from holding BIO-Key International long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BIO-Key International. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BIO-Key International's alpha and beta are two of the key measurements used to evaluate BIO-Key International's performance over the market, the standard measures of volatility play an important role as well.

BIO-Key Stock Against Markets

Picking the right benchmark for BIO-Key International stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BIO-Key International stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BIO-Key International is critical whether you are bullish or bearish towards BIO-Key International at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in BIO-Key International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

BIO-Key International Corporate Directors

BIO-Key International corporate directors refer to members of a BIO-Key International board of directors. The board of directors generally takes responsibility for the BIO-Key International's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BIO-Key International's board members must vote for the resolution. The BIO-Key International board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

Invested in BIO-Key International?

The danger of trading BIO-Key International is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BIO-Key International is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BIO-Key International. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BIO-Key International is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running BIO-Key International price analysis, check to measure BIO-Key International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO-Key International is operating at the current time. Most of BIO-Key International's value examination focuses on studying past and present price action to predict the probability of BIO-Key International's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO-Key International's price. Additionally, you may evaluate how the addition of BIO-Key International to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is BIO-Key International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO-Key International. If investors know BIO-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO-Key International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of BIO-Key International is measured differently than its book value, which is the value of BIO-Key that is recorded on the company's balance sheet. Investors also form their own opinion of BIO-Key International's value that differs from its market value or its book value, called intrinsic value, which is BIO-Key International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO-Key International's market value can be influenced by many factors that don't directly affect BIO-Key International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO-Key International's value and its price as these two are different measures arrived at by different means. Investors typically determine BIO-Key International value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO-Key International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.